RecruitingNot applicableNCT05748990
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia
Studying Other metabolic disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre for Addiction and Mental Health
- Intervention
- Intranasal insulin(drug)
- Enrollment
- 20 target
- Eligibility
- 17-45 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05748990 on ClinicalTrials.govOther trials for Other metabolic disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07536256Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-BeingWaianae Coast Comprehensive Health Center
- RECRUITINGNCT07229170Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss PatientsSan Raffaele Telematic University
- ACTIVE NOT RECRUITINGNCT06485089Effects of Tirzepatide on Blood, Imaging and Breast Tissue BiomarkersUniversity of Kansas Medical Center
- RECRUITINGNANCT05866107App and Body Fat Scale in the Management of Overweight PatientsCapital Medical University